关注
Ashwin Singh Parihar
Ashwin Singh Parihar
Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis
在 wustl.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Mobile phones: Reservoirs for the transmission of nosocomial pathogens
S Pal, D Juyal, S Adekhandi, M Sharma, R Prakash, N Sharma, A Rana, ...
Advanced biomedical research 4 (1), 144, 2015
1302015
Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects
S Park, AS Parihar, L Bodei, TA Hope, N Mallak, C Millo, K Prasad, ...
Journal of Nuclear Medicine 62 (10), 1323-1329, 2021
392021
68Ga-DOTA-RGD2 Positron Emission Tomography/Computed Tomography in Radioiodine Refractory Thyroid Cancer: Prospective Comparison of Diagnostic Accuracy with …
AS Parihar, BR Mittal, R Kumar, J Shukla, A Bhattacharya
Thyroid 30 (4), 557-567, 2020
312020
Novel use of 177Lu-DOTA-RGD2 in treatment of 68Ga-DOTA-RGD2-avid lesions in papillary thyroid cancer with TENIS.
AS Parihar, A Sood, R Kumar, P Bhusari, J Shukla, BR Mittal
European journal of nuclear medicine and molecular imaging, 2018
262018
68Ga-PSMA-HBED-CC-Avid Synchronous Urinary Bladder Paraganglioma in a Patient With Metastatic Prostate Carcinoma.
AS Parihar, SK Vadi, BR Mittal, R Kumar, A Bal, SK Singh
Clinical nuclear medicine 43 (9), e329-e330, 2018
222018
Unusual Case of Diffuse Penile Metastasis of Prostate Cancer on 68Ga PSMA PET/CT Imaging and 177Lu PSMA Posttherapy Scintigraphy.
SK Vadi, R Kumar, BR Mittal, AS Parihar, SK Singh
Clinical nuclear medicine 43 (4), 276-278, 2018
202018
FDG PET/CT–based Response Assessment in Malignancies
AS Parihar, F Dehdashti, RL Wahl
RadioGraphics 43 (4), e220122, 2023
192023
68Ga-Prostate-Specific Membrane Antigen PET/CT and 18F-FDG PET/CT of Primary Signet Ring Cell Breast Adenocarcinoma.
AS Parihar, BR Mittal, A Sood, RK Basher, G Singh
Clinical nuclear medicine 43 (11), e414-e416, 2018
192018
Orbital and brain metastases on 68Ga-PSMA PET/CT in a patient with prostate carcinoma refractory to 177Lu-PSMA and 225Ac-PSMA therapy
AS Parihar, K Chandekar, H Singh, A Sood, BR Mittal
Asia Oceania Journal of Nuclear Medicine and Biology 9 (1), 67-70, 2021
172021
Nephrotoxicity after radionuclide therapies
AS Parihar, S Chopra, V Prasad
Translational Oncology 15 (1), 101295, 2022
162022
18F-FDG PET/CT in Tuberculosis: Can Interim PET/CT Predict the Clinical Outcome of the Patients?
A Sood, BR Mittal, M Modi, R Chhabra, R Verma, N Rana, AS Parihar, ...
Clinical Nuclear Medicine 45 (4), 276-282, 2020
162020
Imaging-Guided Use of Combined 177Lu-DOTATATE and Capecitabine Therapy in Metastatic Mediastinal Paraganglioma
AG Ashwathanarayana, CK Biswal, A Sood, AS Parihar, R Kapoor, ...
Journal of nuclear medicine technology 45 (4), 314-316, 2017
162017
68Ga-PSMA-HBED-CC PET/CT and 18F-FDG PET/CT in Ewing Sarcoma.
AS Parihar, A Sood, BR Mittal, R Kumar, H Singh, SS Dhatt
Clinical Nuclear Medicine 45 (1), e57-e58, 2020
152020
68Ga DOTA-Exendin PET/CT for Detection of Insulinoma in a Patient With Persistent Hyperinsulinemic Hypoglycemia.
AS Parihar, SK Vadi, R Kumar, BR Mittal, H Singh, A Bal, R Walia, ...
Clinical nuclear medicine 43 (8), e285-e286, 2018
152018
IgG4-Related Disease Simulating Carcinoma Colon With Diffuse Peritoneal Carcinomatosis on 18F-FDG PET/CT.
SK Vadi, AS Parihar, R Kumar, H Singh, BR Mittal, A Bal, SK Sinha
Clinical nuclear medicine 43 (7), e247-e249, 2018
142018
Comparison of the diagnostic utility of 99mTc-PSMA scintigraphy versus 68Ga-PSMA-11 PET/CT in the detection of metastatic prostate cancer and dosimetry analysis: a gamma-camera …
B Singh, S Sharma, P Bansal, M Hooda, H Singh, AS Parihar, A Kumar, ...
Nuclear Medicine Communications 42 (5), 482-489, 2021
122021
Evaluation of recurrent parathyroid carcinoma: A new imaging tool in uncommon entity
NTK Thanseer, AS Parihar, A Sood, SK Bhadada, D Dahiya, P Singh, ...
World Journal of Nuclear Medicine 18 (2), 198, 2019
122019
Response to concomitant enzalutamide and 177Lu-PSMA-617 radioligand therapy in ATM-mutated metastatic castration resistant prostate cancer
S Satapathy, CK Das, AS Parihar, A Sood, BR Mittal
Clinical nuclear medicine 46 (7), 582-583, 2021
112021
Diagnostic and prognostic value of 18F-FDG PET/CT imaging in suspected recurrence of male breast cancer
SK Vadi, BR Mittal, A Sood, G Singh, A Bal, AS Parihar, A Bhattacharya, ...
Nuclear medicine communications 40 (1), 63-72, 2019
102019
Pancreatic Malignancy or Not?: Role of 18F-FDG PET/CT in Solving the Diagnostic Dilemma and Evaluating Treatment Response.
AS Parihar, H Singh, R Kumar, V Gupta, BR Mittal
Clinical nuclear medicine 43 (4), e115-e117, 2018
102018
系统目前无法执行此操作,请稍后再试。
文章 1–20